News Bioretec Oy

Equities

BRETEC

FI4000480454

Market Closed - Nasdaq Helsinki Other stock markets 16:29:43 29/04/2024 BST			5-day change	1st Jan Change
2.63 ^EUR	-1.50%		-4.71%	+9.58%

04-05	Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	CI
03-22	Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors	04-26	AQ
Notice of Annual General Meeting (AGM) of Bioretec Ltd	04-08	AQ
Notice of Annual General Meeting (AGM) of Bioretec Ltd	04-05	AQ
Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	04-05	CI
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	03-22	MT
Inside information: Bioretec's RemeOs™ biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office	03-21	AQ
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition	03-21	CI
Bioretec Ltd's Annual Report and Financial Statements 2023 published	03-15	AQ
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant	03-14	MT
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage	03-14	AQ
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage	03-14	CI
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2	03-11	MT
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation	03-08	CI
Bioretec Ltd's financial statements bulletin 2023: Another successful year in the growth trajectory	02-16	AQ
Bioretec and Stephen Industries donate medical devices to Ukraine	02-08	AQ
New shares in Bioretec Ltd subscribed with option rights have been registered into the Trade Register	01-18	AQ
Bioretec Ltd - Managers' transactions	01-05	AQ
Bioretec Ltd's schedule for financial reporting in 2024 and updates in the disclosure policy	12-11	AQ
Bioretec to Initiate Search for New CEO	11-16	MT
Inside information: Bioretec's Board of Directors to initiate a new CEO recruitment process	11-16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bioretec Oy

Equities

BRETEC

FI4000480454

Summary

Filters